Novel priming agents for liquid biopsy diagnostics
HQ Country
Cambridge, United States
Employees
1-10
Founded
2023
HQ State/Province
Massachusetts
Funding Category
Seed
HQ Full Address
Cambridge, Massachusetts, United States
Product Features & Capabilities
Priming agents to increase cfDNA in blood
Enhances genomic information quality for cancer diagnostics
Improves clinical outcomes in oncology
Other Considerations
Founded by Dr. Sangeeta Bhatia, Dr. Chris Love, and Dr. Viktor Adalsteinsson; Research published in Science; Presented at leading international conferences; MIT and Broad Institute collaboration